• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由于雄激素受体失活导致癌症相关成纤维细胞中 LMO2 的上调,在雄激素剥夺后诱导前列腺癌的非细胞自主生长。

LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China; Institute of Urology, Shanghai Jiao Tong University, Shanghai, 200080, China.

Department of Urology, Jiangsu Jiangyin People's Hospital, Jiangyin, 214400, China.

出版信息

Cancer Lett. 2021 Apr 10;503:138-150. doi: 10.1016/j.canlet.2021.01.017. Epub 2021 Jan 24.

DOI:10.1016/j.canlet.2021.01.017
PMID:33503448
Abstract

The androgen receptor (AR) is expressed in prostate fibroblasts in addition to normal prostate epithelial cells and prostate cancer (PCa) cells. Moreover, AR activation in fibroblasts dramatically influences prostate cancer (PCa) cell behavior. Androgen deprivation leads to deregulation of AR downstream target genes in both fibroblasts and PCa cells. Here, we identified LIM domain only 2 (LMO2) as an AR target gene in prostate fibroblasts using ChIP-seq and revealed that LMO2 can be repressed directly by AR through binding to androgen response elements (AREs), which results in LMO2 overexpression after AR deactivation due to normal prostate fibroblasts to cancer-associated fibroblasts (CAFs) transformation or androgen deprivation therapy. Next, we investigated the mechanisms of LMO2 overexpression in fibroblasts and the role of this event in non-cell-autonomous promotion of PCa cells growth in the androgen-independent manner through paracrine release of IL-11 and FGF-9. Collectively, our data suggest that AR deactivation deregulates LMO2 expression in prostate fibroblasts, which induces castration resistance in PCa cells non-cell-autonomously through IL-11 and FGF-9.

摘要

雄激素受体(AR)不仅在正常前列腺上皮细胞和前列腺癌(PCa)细胞中表达,还在前列腺成纤维细胞中表达。此外,成纤维细胞中 AR 的激活会显著影响前列腺癌(PCa)细胞的行为。雄激素剥夺会导致成纤维细胞和 PCa 细胞中 AR 下游靶基因的失调。在这里,我们使用 ChIP-seq 鉴定了 LIM 结构域只有 2 种(LMO2)作为前列腺成纤维细胞中的 AR 靶基因,并揭示了 LMO2 可以通过与雄激素反应元件(AREs)结合直接被 AR 抑制,导致 AR 失活后 LMO2 过表达,原因是正常前列腺成纤维细胞向癌相关成纤维细胞(CAFs)转化或雄激素剥夺治疗。接下来,我们研究了成纤维细胞中 LMO2 过表达的机制以及这种事件通过旁分泌释放 IL-11 和 FGF-9 以非细胞自主方式促进 PCa 细胞生长的作用。总的来说,我们的数据表明,AR 失活会使前列腺成纤维细胞中的 LMO2 表达失调,从而通过 IL-11 和 FGF-9 以非细胞自主的方式诱导 PCa 细胞的去势抵抗。

相似文献

1
LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.由于雄激素受体失活导致癌症相关成纤维细胞中 LMO2 的上调,在雄激素剥夺后诱导前列腺癌的非细胞自主生长。
Cancer Lett. 2021 Apr 10;503:138-150. doi: 10.1016/j.canlet.2021.01.017. Epub 2021 Jan 24.
2
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis.癌相关成纤维细胞通过上调胆固醇和类固醇生物合成促进前列腺肿瘤生长和进展。
Cell Commun Signal. 2020 Jan 24;18(1):11. doi: 10.1186/s12964-019-0505-5.
3
LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11.仅含LIM结构域蛋白2在前列腺基质细胞中的过表达通过白细胞介素-11的旁分泌促进前列腺癌进展。
Oncotarget. 2016 May 3;7(18):26247-58. doi: 10.18632/oncotarget.8359.
4
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer.靶向糖皮质激素受体特征基因单胺氧化酶-A 可增强晚期前列腺癌化疗和抗雄激素治疗的疗效。
Oncogene. 2021 Apr;40(17):3087-3100. doi: 10.1038/s41388-021-01754-0. Epub 2021 Apr 1.
5
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamide.组蛋白乙酰转移酶 1 上调雄激素受体表达,调节 CRPC 细胞对恩杂鲁胺的耐药性。
Clin Transl Med. 2021 Jul;11(7):e495. doi: 10.1002/ctm2.495.
6
Loss of AR-regulated AFF3 contributes to prostate cancer progression and reduces ferroptosis sensitivity by downregulating ACSL4 based on single-cell sequencing analysis.基于单细胞测序分析,AR 调控的 AFF3 丢失导致前列腺癌进展,并通过下调 ACSL4 降低铁死亡敏感性。
Apoptosis. 2024 Oct;29(9-10):1679-1695. doi: 10.1007/s10495-024-01941-w. Epub 2024 Mar 13.
7
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.前列腺癌相关成纤维细胞(CAFs)中雄激素受体信号的丧失促进 CCL2 和 CXCL8 介导的癌细胞迁移。
Mol Oncol. 2018 Aug;12(8):1308-1323. doi: 10.1002/1878-0261.12327. Epub 2018 Jul 10.
8
Galectin-3 Is Implicated in Tumor Progression and Resistance to Anti-androgen Drug Through Regulation of Androgen Receptor Signaling in Prostate Cancer.半乳糖凝集素-3通过调节前列腺癌中的雄激素受体信号传导参与肿瘤进展和抗雄激素药物耐药。
Anticancer Res. 2017 Jan;37(1):125-134. doi: 10.21873/anticanres.11297.
9
18β-Glycyrrhetinic acid synergizes with enzalutamide to counteract castration-resistant prostate cancer by inhibiting OATP2B1 uptake of dehydroepiandrosterone sulfate.18β-甘草次酸与恩杂鲁胺协同作用,通过抑制OATP2B1对硫酸脱氢表雄酮的摄取来对抗去势抵抗性前列腺癌。
Eur J Pharmacol. 2024 Nov 15;983:176995. doi: 10.1016/j.ejphar.2024.176995. Epub 2024 Sep 12.
10
Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.雄激素受体丝氨酸 81 的磷酸化与其在去势抵抗性前列腺癌中的再激活有关。
Cancer Lett. 2018 Dec 1;438:97-104. doi: 10.1016/j.canlet.2018.09.014. Epub 2018 Sep 11.

引用本文的文献

1
Identification of asporin as a HER3 ligand exposes a therapeutic vulnerability in prostate cancer.鉴定出骨桥蛋白作为HER3配体揭示了前列腺癌的一个治疗弱点。
JCI Insight. 2025 Aug 22;10(16). doi: 10.1172/jci.insight.187151.
2
The cancer-associated fibroblasts interact with malignant T cells in mycosis fungoides and promote the disease progression.癌症相关成纤维细胞在蕈样肉芽肿中与恶性T细胞相互作用,并促进疾病进展。
Front Immunol. 2025 Feb 3;15:1474564. doi: 10.3389/fimmu.2024.1474564. eCollection 2024.
3
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities.
非前列腺恶性肿瘤中的雄激素受体信号传导:挑战与机遇
Nat Rev Cancer. 2025 Feb;25(2):93-108. doi: 10.1038/s41568-024-00772-w. Epub 2024 Nov 25.
4
Phosphodiesterase type 5 inhibitor tadalafil reduces prostatic fibrosis via MiR-3126-3p/FGF9 axis in benign prostatic hyperplasia.磷酸二酯酶 5 抑制剂他达拉非通过 miR-3126-3p/FGF9 轴减少良性前列腺增生中的前列腺纤维化。
Biol Direct. 2024 Aug 2;19(1):61. doi: 10.1186/s13062-024-00504-y.
5
Sex differences in cancer and immunotherapy outcomes: the role of androgen receptor.癌症和免疫疗法疗效的性别差异:雄激素受体的作用。
Front Immunol. 2024 May 28;15:1416941. doi: 10.3389/fimmu.2024.1416941. eCollection 2024.
6
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.定义肿瘤微环境中的癌症相关成纤维细胞(CAFs):癌症免疫治疗的新机遇和临床试验的进展。
Mol Cancer. 2023 Oct 2;22(1):159. doi: 10.1186/s12943-023-01860-5.
7
LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.LMO2 通过与转录共激活因子 LDB1 相互作用促进 AML 的发生。
Cell Death Dis. 2023 Aug 12;14(8):518. doi: 10.1038/s41419-023-06039-w.
8
Cancer-Associated Fibroblast: Role in Prostate Cancer Progression to Metastatic Disease and Therapeutic Resistance.癌相关成纤维细胞:在前列腺癌向转移性疾病和治疗抵抗进展中的作用。
Cells. 2023 Mar 4;12(5):802. doi: 10.3390/cells12050802.
9
Identification and Validation of FGF-Related Prognostic Signatures in Prostate Cancer.识别和验证前列腺癌中与 FGF 相关的预后标志物。
Dis Markers. 2023 Feb 21;2023:7342882. doi: 10.1155/2023/7342882. eCollection 2023.
10
Cancer-Associated Fibroblast Heterogeneity, Activation and Function: Implications for Prostate Cancer.癌症相关成纤维细胞的异质性、激活与功能:对前列腺癌的影响。
Biomolecules. 2022 Dec 29;13(1):67. doi: 10.3390/biom13010067.